- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04113044
Go Fit Fast, Recovery Trajectory Using PROMIS®, Linking PROMIS®
Clinical Priority Program (CPP) Clinical Outcome Measurement of Fracture Treatment:
Prospective data will be collected in approximately 3500 patients (700 per 5 injury groups).
Patients will be followed up according to the standard (routine) for up to 1 year after the treatment.
Data collection will include underlying disease, treatment details, patient reported outcomes (PROs), anticipated or procedure-related adverse events (i.e. complications), and radiological outcomes.
Study Overview
Status
Conditions
Detailed Description
More in detail this observational study includes the following sub-projects:
I) Weight -bearing and Gait Observation for Fully Individualized Treatment and Aftercare Following Surgery and Trauma
Objectives:
To analyse the association between automated, sensor-based patient activity and loading data, and clinical (Patient Reported Outcomes [PROs]) and radiographic outcome during fracture healing.
II) Recovery Trajectory using PROMIS®: Defining the Recovery Trajectory using PROMIS® to Optimize Decision-making and Outcomes following Extremity Fractures
Objectives:
- To identify the factors predictive of longer term magnitude of limitations after extremity fractures (using PROMs)
- To assess minimal clinically important difference (MCID) and substantial clinical benefit (SCB) in PROM scores
- To define recovery trajectories of PROMs i.e. range, normative limits and score thresholds
III) Linking PROMIS®: Linking of PROMIS Measures to Legacy Measures in an Orthopaedic Patient Population
Objectives:
- Administer and collect responses to the PROMIS PF/UE and PAIN INT and the four orthopaedic legacy measures in the same group of orthopaedic trauma patients.
- Apply the methods of item-response theory (IRT) linking to establish a common standardized metric.
- Develop equations for conversion of a PROMIS PF/UE and PAIN INT score to each of the specified legacy measures and vice-versa.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Locations
-
-
-
Innsbruck, Austria, 6020
- Univ.-Klinik für Orthopädie und Traumatologie
-
-
-
-
-
Bogotá, Colombia, 110121
- Fundacion Santa Fe de Bogota
-
-
-
-
-
Berlin, Germany, 13353
- Centrum für Muskuloskeletale Chirurgie (CMSC) Charite - Universitätsmedizin Berlin
-
Freiburg im Breisgau, Germany, 79106
- University Hospital Freiburg
-
Homburg, Germany, 66421
- Saarland University Hospital Department of Trauma, Hand and Reconstructive Surgery
-
Murnau am Staffelsee, Germany, 82418
- Institut für Biomechanik Berufsgenossenschaftliche Unfallklinik Murnau
-
Tübingen, Germany, 72076
- Abteilung für Unfall- und Wiederherstellungschirurgie BG Klinik Tübingen
-
-
-
-
-
Groningen, Netherlands, 9700
- University Medical Center Groningen
-
Zwolle, Netherlands, 8000
- Isala Clinics
-
-
-
-
-
London, United Kingdom, E14DG
- Barts Health NHS Trust
-
Oxford, United Kingdom, OX39DU
- Oxford University Hospitals NHS Foundation Trust
-
-
-
-
California
-
Los Angeles, California, United States, 90048
- Cedars-Sinai Department of Orthopaedics
-
-
Florida
-
Miami, Florida, United States, 33136
- University of Miami, Jackson Memorial Hospital Ryder Trauma Center
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02114
- Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
-
-
Texas
-
Austin, Texas, United States, 78712
- The Value Institute / Department of Surgery and Peri-operative Care. Dell Medical School, University of Texas at Austin
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 18 years and older
Diagnosis of one of, isolated injury
- Hip fracture
- Tibial shaft fracture (with and without associated fibular fracture)
- Ankle/pilon fracture
- Proximal humerus fracture
- Distal radius fracture
- English, German, or Spanish speaking
Informed consent obtained, i.e.:
- Ability to understand the content of the patient information/ICF
- Willingness and ability to participate in the clinical investigation according to the Clinical Investigation Plan (CIP)
- Signed and dated EC/IRB approved written informed consent
Exclusion Criteria:
- More than 21 days from day of injury to day of surgery / day of nonoperative treatment decision
- Patients with multiple fractures
- Pathological fractures due to cancer
- Recent history of substance abuse (i.e. recreational drugs, alcohol) that would preclude reliable assessment
- Pregnancy or women planning to conceive within the study period
- Patients who are not able to provide independent written informed consent unless defined and IRB/IEC-approved procedures for consenting such vulnerable patients are in place
- Prisoners
- Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study
- Patients unable to likely achieve anticipated Follow-up (FU)
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Go Fit Fast: Radiographic measurements, Patient related outcomes (PROs: PROMIS, HOOS, KOOS,), Loading/Activity pattern analysis
Time Frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
Recovery Trajectories PROMIS/Linking PROMIS: PROs: PROMIS, HOOS, KOOS, QuickDASH, FAAM
Time Frame: from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PROs that measure physical limitations:
|
from the pre-treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
PROMIS Pain Interference
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PROMIS Pain Interference (8 questions) assesses the impact of pain on common activities of daily life including social, cognitive, emotional, physical, and recreational aspects.
The higher score represents a higher pain level
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
PROMIS Depression
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PROMIS Depression assesses negative mood (sadness, guilt), views of self (worthlessness, self-criticism) and diminished positive affect and engagement (loss of interest) within the previous week.
The higher score represents higher depression level
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
PROMIS Anxiety
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PROMIS Anxiety assesses levels of anxiety through measuring aspects of fear (e.g.
fearfulness, feelings of panic), anxious misery (e.g.
worry, dread), hyperarousal (e.g.
tension, nervousness, restless) and some somatic symptoms related to arousal (e.g.
dizziness).
The higher score represent the higher level of anxiety
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
PROMIS Ability to Participate in Social Roles and Activities
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PROMIS Ability to Participate in Social Roles and Activities item bank assesses the perceived ability to perform one's usual social roles and activities.
The higher score represents better ability for social roles
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
Pain Self-Efficacy Questionnaire (PSEQ)-2
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PSEQ-2 assesses adaptive coping strategy and the confidence one can achieve one's goals in spite of pain.
Items are scored on a 7-point Likert scale and added to form a total score ranging from 0 to 12, with higher scores indicating greater self-efficacy
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
Patient Activation Measure (PAM)-10
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
PAM-10 assesses activation and the personal and psychological competencies.
PAM segments individuals into one of four activation levels along an empirically derived 100-point scale.
Individuals in the highest activation level are proactive with their health, have developed strong self-management skills, and are resilient in times of stress or change.
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
|
Cognitive assessment
Time Frame: Pre-treatment
|
The MiniCog is a 3-minute instrument assessing cognitive impairment.
It consists of two components, a 3-item recall test for memory and a simply scored clock drawing test.
A total score ranges from 0 to 5. A score of zero, one or two out of five points in total, indicates a concern in cognitive functioning.
|
Pre-treatment
|
|
Mobility Scores
Time Frame: Pre-treatment
|
Parker Mobility Scale assess the patient's ability to perform indoor walking, outdoor walking, and shopping before the fracture.
A score ranges between 0 and 3 (0 = not at all, 1 = with help from another person, 2 = with an aid, and 3 = no difficulty and no aid) for each function, resulting in a total score ranging from 0 (no walking ability at all) to 9 (fully independent).
|
Pre-treatment
|
|
RUSH score
Time Frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)
|
Radiographic Union Score in Hip Fractures
|
from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)
|
|
RUST score
Time Frame: from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)
|
Radiographic Union Score for Tibia
|
from the 6-8 weeks until 12 months after the treatment (surgical or not-surgical)
|
|
Numeric Rating Scale (NRS) Pain
Time Frame: from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
An ordinal scale from 0 to 10 with 0 indicating no pain and 10 indicating extreme pain.
|
from the treatment assessment until 12 months after the treatment (surgical or not-surgical)
|
Collaborators and Investigators
Sponsor
Investigators
- Principal Investigator: Marilyn Heng, Massachusetts General Hospital Harvard Orthopaedic Trauma Initiative
- Principal Investigator: Prakash Jayakumar, Dell Medical School, University of Texas at Austin
- Principal Investigator: Tim Pohlemann, Saarland University Hospital
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Shoulder Injuries
- Wounds and Injuries
- Leg Injuries
- Fractures, Bone
- Femoral Fractures
- Hip Injuries
- Arm Injuries
- Ankle Injuries
- Wrist Injuries
- Wrist Fractures
- Ankle Fractures
- Hip Fractures
- Shoulder Fractures
- Tibial Fractures
- Health Services Administration
- Health Care Quality, Access, and Evaluation
- Investigative Techniques
- Epidemiologic Methods
- Data Collection
- Health Care Evaluation Mechanisms
- Quality of Health Care
- Public Health
- Environment and Public Health
- Health Care Economics and Organizations
- Outcome Assessment, Health Care
- Outcome and Process Assessment, Health Care
- Surveys and Questionnaires
- Health Planning
- Health Care Surveys
- Health Services Research
- Patient Outcome Assessment
- Patient Reported Outcome Measures
Other Study ID Numbers
- CPP Patient Outcome
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Hip Fractures
-
Khoo Teck Puat HospitalMinistry of Health, SingaporeActive, not recruitingHip Fracture Surgeries | Post-operative Hip Fractures RecoverySingapore
-
San Giovanni di Dio HospitalRecruitingHip Surgery | Hip ArthroplastyItaly
-
Smith & Nephew, Inc.Terminated
-
Medical Centre LeeuwardenNot yet recruitingHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)Netherlands
-
Texas Tech University Health Sciences Center, El...CompletedHip Fractures (i.e. Femoral Neck or Intertrochanteric Hip Fractures)United States
-
Gaziantep City HospitalCompletedFemoral Neck Fractures | Hip SurgeryTurkey (Türkiye)
-
Carilion ClinicCompleted
-
Sheffield Teaching Hospitals NHS Foundation TrustRecruitingHip FractureUnited Kingdom
-
FH ORTHOTerminatedHip Fractures | Hip DiseaseFrance
-
Zhenjiang First People's HospitalCompletedHip Fractures | Hip DiseaseChina
Clinical Trials on All treatments will remain the standard (routine) care procedures based on individual clinician's judgment and the patient characteristics.
-
Radboud University Medical CenterCompletedTissue and Organ ProcurementNetherlands
-
Tehran University of Medical SciencesUnknownMetabolic Syndrome XIran, Islamic Republic of
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); Fordham UniversityCompletedAdvanced Solid Tumor DiseasesUnited States
-
Rennes University HospitalRecruitingHysterectomies for Low- or Intermediate-risk Endometrial CarcinomaFrance